Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.

[1]  M. Jucker,et al.  Early onset amyloid lesions lead to severe neuritic abnormalities and local, but not global neuron loss in APPPS1 transgenic mice , 2011, Neurobiology of Aging.

[2]  Jason T. Stevens,et al.  Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation , 2011, Nature.

[3]  V. Bohr,et al.  DNA repair deficiency in neurodegeneration , 2011, Progress in Neurobiology.

[4]  F. Sohrabji,et al.  Vascular and metabolic dysfunction in Alzheimer's disease: a review , 2011, Experimental biology and medicine.

[5]  L. Samson,et al.  The Cycad Genotoxin MAM Modulates Brain Cellular Pathways Involved in Neurodegenerative Disease and Cancer in a DNA Damage-Linked Manner , 2011, PloS one.

[6]  E. Kavanagh,et al.  Caspase signalling controls microglia activation and neurotoxicity , 2011, Nature.

[7]  P. Aisen,et al.  A phase II trial of huperzine A in mild to moderate Alzheimer disease , 2011, Neurology.

[8]  C. Iadecola,et al.  Amyloid β-Induced Impairments in Hippocampal Synaptic Plasticity Are Rescued by Decreasing Mitochondrial Superoxide , 2011, The Journal of Neuroscience.

[9]  P. Hemachandra Reddy,et al.  Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. , 2011, Human molecular genetics.

[10]  P. Reddy,et al.  Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. , 2011, Biochimica et biophysica acta.

[11]  Lucia Pagani,et al.  Amyloid-Beta Interaction with Mitochondria , 2011, International journal of Alzheimer's disease.

[12]  Jee Hoon Roh,et al.  Neuronal activity regulates the regional vulnerability to amyloid-β deposition , 2011, Nature Neuroscience.

[13]  D. Eisenberg.  An evolutionary review of human telomere biology: The thrifty telomere hypothesis and notes on potential adaptive paternal effects , 2011, American journal of human biology : the official journal of the Human Biology Council.

[14]  L. Chin,et al.  Telomere dysfunction induces metabolic and mitochondrial compromise , 2011, Nature.

[15]  C. Harris,et al.  p53 governs telomere regulation feedback too, via TRF2 , 2011, Aging.

[16]  M. Shammas.  Telomeres, lifestyle, cancer, and aging , 2011, Current opinion in clinical nutrition and metabolic care.

[17]  L. Schneider,et al.  Report of the task force on designing clinical trials in early (predementia) AD , 2010, Neurology.

[18]  S. Hekimi,et al.  Reactive Oxygen Species and Aging in Caenorhabditis elegans: Causal or Casual Relationship? , 2010, Antioxidants & redox signaling.

[19]  K. Jellinger,et al.  Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[20]  G. McKhann,et al.  Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model , 2010, Proceedings of the National Academy of Sciences.

[21]  V. Bohr,et al.  The mitochondrial transcription factor A functions in mitochondrial base excision repair. , 2010, DNA repair.

[22]  D. Gordon,et al.  The Emerging Role of Telomerase Reverse Transcriptase in Mitochondrial DNA Metabolism , 2010, Journal of nucleic acids.

[23]  K. A. Wollen,et al.  Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. , 2010, Alternative medicine review : a journal of clinical therapeutic.

[24]  C. Franceschi,et al.  Evidence for Sub-Haplogroup H5 of Mitochondrial DNA as a Risk Factor for Late Onset Alzheimer's Disease , 2010, PloS one.

[25]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[26]  H. Kestler,et al.  Lifestyle impacts on the aging‐associated expression of biomarkers of DNA damage and telomere dysfunction in human blood , 2010, Aging cell.

[27]  V. Bohr,et al.  Mitochondrial DNA repair and association with aging – An update , 2010, Experimental Gerontology.

[28]  Han-Chang Huang,et al.  Cu(II) interaction with amyloid-β peptide: A review of neuroactive mechanisms in AD brains , 2010, Brain Research Bulletin.

[29]  C. Holmes,et al.  Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis , 2010, Acta Neuropathologica.

[30]  N. Delibaş,et al.  Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. , 2010, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[31]  C. Geula,et al.  Neuronal and axonal loss are selectively linked to fibrillar amyloid-{beta} within plaques of the aged primate cerebral cortex. , 2010, The American journal of pathology.

[32]  P. Reddy,et al.  Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. , 2010, Journal of Alzheimer's disease : JAD.

[33]  C. Cotman,et al.  Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. , 2010, Journal of Alzheimer's disease : JAD.

[34]  J. Bennett,et al.  The mitochondrial secret(ase) of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[35]  P. Reddy,et al.  Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. , 2010, Journal of Alzheimer's disease : JAD.

[36]  B. Demple,et al.  DNA repair in mammalian mitochondria: Much more than we thought? , 2010, Environmental and molecular mutagenesis.

[37]  Kanae Iijima-Ando,et al.  A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration. , 2010, Human molecular genetics.

[38]  Nick C Fox,et al.  11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study , 2010, The Lancet Neurology.

[39]  B. Yankner,et al.  Neural mechanisms of ageing and cognitive decline , 2010, Nature.

[40]  Ronald A. DePinho,et al.  Linking functional decline of telomeres, mitochondria and stem cells during ageing , 2010, Nature.

[41]  V. Bohr,et al.  Differential age-related changes in mitochondrial DNA repair activities in mouse brain regions , 2010, Neurobiology of Aging.

[42]  B. Morris,et al.  The molecular basis of longevity, and clinical implications. , 2010, Maturitas.

[43]  Stephen A Hearn,et al.  Mitochondrial Mislocalization Underlies Aβ42-Induced Neuronal Dysfunction in a Drosophila Model of Alzheimer's Disease , 2009, PloS one.

[44]  María A Blasco,et al.  Telomere Shortening in Neural Stem Cells Disrupts Neuronal Differentiation and Neuritogenesis , 2009, The Journal of Neuroscience.

[45]  P. Wong,et al.  The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential , 2009, The Journal of Neuroscience.

[46]  L. Murri,et al.  Is there a primary role of the mitochondrial genome in Alzheimer’s disease? , 2009, Journal of bioenergetics and biomembranes.

[47]  H. Fukui,et al.  The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation , 2009, Journal of bioenergetics and biomembranes.

[48]  Yan Wang,et al.  Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice , 2009, The Journal of Neuroscience.

[49]  K. Rudolph,et al.  Role of telomere dysfunction in aging and its detection by biomarkers , 2009, Journal of Molecular Medicine.

[50]  Russell H. Swerdlow,et al.  The Alzheimer's disease mitochondrial cascade hypothesis: An update , 2009, Experimental Neurology.

[51]  P. Reddy,et al.  Is multiple sclerosis a mitochondrial disease? , 2009, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

[52]  S. Di Giovanni,et al.  The non‐apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon , 2009, EMBO reports.

[53]  In Hye Lee,et al.  Bmi1 regulates mitochondrial function and the DNA damage response pathway , 2009, Nature.

[54]  Nick C Fox,et al.  Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders , 2009, Current Alzheimer research.

[55]  Alicia R. Desilets,et al.  Role of Huperzine a in the Treatment of Alzheimer's Disease , 2009, The Annals of pharmacotherapy.

[56]  Hong-Zhuan Chen,et al.  Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis , 2009, Journal of Neural Transmission.

[57]  M. Tabaton,et al.  The up‐regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α , 2009, Journal of neurochemistry.

[58]  F. Coppedè,et al.  DNA damage and repair in Alzheimer's disease. , 2009, Current Alzheimer research.

[59]  A. Fersht,et al.  Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53 , 2008, Nucleic acids research.

[60]  K. Rudolph,et al.  Determining the influence of telomere dysfunction and DNA damage on stem and progenitor cell aging – what markers can we use? , 2008, Experimental Gerontology.

[61]  G. McKhann,et al.  Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease , 2008, Nature Medicine.

[62]  B. Winblad,et al.  The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae , 2008, Proceedings of the National Academy of Sciences.

[63]  M. Manns,et al.  Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease , 2008, Proceedings of the National Academy of Sciences.

[64]  Á. Simonyi,et al.  Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons , 2008, Journal of neurochemistry.

[65]  F. D. D. Fagagna.  Living on a break: cellular senescence as a DNA-damage response , 2008, Nature Reviews Cancer.

[66]  S. Younkin,et al.  Plasma amyloid β protein is elevated in late-onset Alzheimer disease families , 2008, Neurology.

[67]  M. Beal,et al.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. , 2008, Trends in molecular medicine.

[68]  M. Findeis.  The role of amyloid β peptide 42 in Alzheimer's disease , 2007 .

[69]  Gabriele Siciliano,et al.  Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? , 2007, Antioxidants & redox signaling.

[70]  Reham M. Abdel-Kader,et al.  Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? , 2007, Antioxidants & redox signaling.

[71]  Hirokazu Fukui,et al.  Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease , 2007, Proceedings of the National Academy of Sciences.

[72]  M. Mattson,et al.  Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment , 2007, Nucleic acids research.

[73]  M. Hegde,et al.  A new evidence for DNA nicking property of amyloid beta-peptide (1-42): relevance to Alzheimer's disease. , 2007, Archives of biochemistry and biophysics.

[74]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[75]  W. Dröge,et al.  Oxidative stress and aberrant signaling in aging and cognitive decline , 2007, Aging cell.

[76]  M. Kelley,et al.  DNA repair in neurons: so if they don't divide what's to repair? , 2007, Mutation research.

[77]  S. Orrenius.  Reactive Oxygen Species in Mitochondria-Mediated Cell Death , 2007, Drug metabolism reviews.

[78]  M. Beal,et al.  Alzheimer's APP mangles mitochondria , 2006, Nature Medicine.

[79]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[80]  Hartwig Wolburg,et al.  Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology , 2006, EMBO reports.

[81]  N. Walsh.  Huperzine A for Alzheimer's Disease , 2006 .

[82]  D. Galati,et al.  Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction , 2006, The Journal of Neuroscience.

[83]  V. Bohr,et al.  Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner , 2006, Neurobiology of Aging.

[84]  R. Kayed,et al.  ERK1/2 Activation Mediates Aβ Oligomer-induced Neurotoxicity via Caspase-3 Activation and Tau Cleavage in Rat Organotypic Hippocampal Slice Cultures* , 2006, Journal of Biological Chemistry.

[85]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[86]  J. Quinn,et al.  Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.

[87]  P. Reddy,et al.  Mitochondrial Oxidative Damage in Aging and Alzheimer's Disease: Implications for Mitochondrially Targeted Antioxidant Therapeutics , 2006, Journal of biomedicine & biotechnology.

[88]  D. Kelly,et al.  PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. , 2006, The Journal of clinical investigation.

[89]  M. Evans,et al.  Does measurement of oxidative damage to DNA have clinical significance? , 2006, Clinica chimica acta; international journal of clinical chemistry.

[90]  W. Markesbery,et al.  Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment , 2006, Journal of neurochemistry.

[91]  J. Hardy,et al.  Has the amyloid cascade hypothesis for Alzheimer's disease been proved? , 2006, Current Alzheimer research.

[92]  X. Chen,et al.  Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease , 2005 .

[93]  C. Almeida,et al.  Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease , 2005, Neurobiology of Aging.

[94]  J. Hardy,et al.  Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice , 2005, Neuron.

[95]  N. Hamasaki,et al.  Mitochondrial Transcription Factor A in the Maintenance of Mitochondrial DNA , 2005, Annals of the New York Academy of Sciences.

[96]  M A Lovell,et al.  Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease , 2005, Journal of neurochemistry.

[97]  G. Perry,et al.  Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease , 2005, Journal of the Neurological Sciences.

[98]  C. Kenyon.  The Plasticity of Aging: Insights from Long-Lived Mutants , 2005, Cell.

[99]  P. Reddy,et al.  Time‐course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging , 2005, Journal of neurochemistry.

[100]  C. Masters,et al.  Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42 , 2005, The Journal of Neuroscience.

[101]  G. Fiskum,et al.  Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. , 2004, Cell calcium.

[102]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[103]  M. Beal,et al.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[104]  J. Quinn,et al.  Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. , 2004, Human molecular genetics.

[105]  J. Barrett,et al.  Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks , 2004, Nature Cell Biology.

[106]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[107]  H. Vinters,et al.  Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice , 2003, Neurological research.

[108]  H. Itoh,et al.  P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. , 2003, Cancer research.

[109]  S. Dimauro,et al.  Mitochondrial respiratory-chain diseases. , 2003, The New England journal of medicine.

[110]  V. Bohr,et al.  Base excision repair capacity in mitochondria and nuclei: tissue‐specific variations , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  W. Ma,et al.  Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures , 2002, Neuroscience.

[112]  G. Perry,et al.  Oxidative Stress Increases Expression and Activity of BACE in NT2 Neurons , 2002, Neurobiology of Disease.

[113]  H. Uramoto,et al.  Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNA. , 2002, Biochemical and biophysical research communications.

[114]  Zhenxin Zhang,et al.  [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]. , 2002, Zhonghua yi xue za zhi.

[115]  Jun Chen,et al.  Age‐dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria , 2002, Journal of neurochemistry.

[116]  J. Campisi.  Cellular senescence as a tumor-suppressor mechanism. , 2001, Trends in cell biology.

[117]  Zhongmao Guo,et al.  Does oxidative damage to DNA increase with age? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[118]  I. Thompson,et al.  A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. , 2001, Nucleic acids research.

[119]  N. Souza-Pinto.  DNA repair and aging in mouse liver: 8-oxodG glycosylase activity increase in mitochondrial but not in nuclear extracts , 2001 .

[120]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[121]  H. Chung,et al.  The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain. , 2000, Biochemical and biophysical research communications.

[122]  D. Butterfield,et al.  Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.

[123]  S. Rabacchi,et al.  Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid , 2000, The Journal of Neuroscience.

[124]  W. Markesbery,et al.  Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF , 1999, Journal of neurochemistry.

[125]  A. Smith,et al.  The cell division cycle and the pathophysiology of Alzheimer's disease. , 1998, Neuroscience.

[126]  W. Markesbery,et al.  Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease , 1998, Journal of neurochemistry.

[127]  B. Sommer,et al.  Neuron loss in APP transgenic mice , 1998, Nature.

[128]  Bruce A. Yankner,et al.  Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.

[129]  N. Cairns,et al.  An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease , 1997, Journal of neurochemistry.

[130]  A. Collins,et al.  The comet assay: what can it really tell us? , 1997, Mutation research.

[131]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[132]  M. Beal,et al.  Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.

[133]  X. Chai,et al.  Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. , 1995, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[134]  I. Kanazawa,et al.  APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain. , 1994, The Journal of biological chemistry.

[135]  C. Cross,et al.  Oxygen-derived species: their relation to human disease and environmental stress. , 1994, Environmental health perspectives.

[136]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[137]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[138]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[139]  K. Hirayasu,et al.  Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated Nal and SDS. , 1994, Nucleic acids research.

[140]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[141]  M. Sofroniew,et al.  Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. , 1994, Genes & development.

[142]  M J Ball,et al.  beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[143]  Khadija Iqbal,et al.  Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. , 1993, Archives of biochemistry and biophysics.

[144]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[145]  C. Clark,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1990, Neurology.

[146]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[147]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[148]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[149]  R. Lightowlers,et al.  DNA repair in organelles: Pathways, organization, regulation, relevance in disease and aging. , 2011, Biochimica et biophysica acta.

[150]  M. Mancuso,et al.  Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA. , 2010, Advances in experimental medicine and biology.

[151]  M. Beal,et al.  Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. , 2010, Biochimica et biophysica acta.

[152]  R. Swerdlow,et al.  Polymorphic variation in cytochrome oxidase subunit genes. , 2010, Journal of Alzheimer's disease : JAD.

[153]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[154]  A. Collins.  Investigating oxidative DNA damage and its repair using the comet assay. , 2009, Mutation research.

[155]  F. Cecconi,et al.  Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes. , 2009, Journal of Alzheimer's disease : JAD.

[156]  Han-Chang Huang,et al.  Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[157]  A. Fersht,et al.  Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p 53 , 2009 .

[158]  J. Blass.  The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha , 2009 .

[159]  J. Quinn,et al.  Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[160]  S. Younkin,et al.  Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. , 2008, Neurology.

[161]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[162]  P. Reddy,et al.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease , 2007, NeuroMolecular Medicine.

[163]  M. Findeis.  The role of amyloid beta peptide 42 in Alzheimer's disease. , 2007, Pharmacology & therapeutics.

[164]  F. LaFerla,et al.  Intracellular amyloid-beta in Alzheimer's disease. , 2007, Nature reviews. Neuroscience.

[165]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[166]  C. Almeida,et al.  Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. , 2005, Neurobiology of aging.

[167]  X. Chen,et al.  Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[168]  R. Swerdlow,et al.  A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. , 2004, Medical hypotheses.

[169]  D. Butterfield.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. , 2002, Free radical research.

[170]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[171]  S. Rabacchi,et al.  Caspase-2 mediates neuronal cell death induced by beta-amyloid. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[172]  B. Ames,et al.  8-Hydroxydeoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. , 1999, Methods in enzymology.

[173]  S. Piperakis,et al.  Comet assay for nuclear DNA damage. , 1999, Methods in enzymology.

[174]  C. Geula,et al.  Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. , 1998, Nature medicine.

[175]  H. Kleiner,et al.  Linking the metabolism of hydroquinone to its nephrotoxicity and nephrocarcinogenicity. , 1996, Advances in experimental medicine and biology.

[176]  S. Adams,et al.  Measurement of 8-OHdG in DNA by HPLC/ECD: the importance of DNA purity. , 1996, BioTechniques.

[177]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.

[178]  C. Behl,et al.  Hydrogen peroxide mediates amyloid beta protein toxicity. , 1994, Cell.

[179]  T. Iwatsubo,et al.  Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). , 1994, Neuron.

[180]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.